Antenatal magnesium sulfate to prevent cerebral palsy
2021 ◽
pp. fetalneonatal-2021-321817
Keyword(s):
Magnesium sulfate given to women before birth at <30 weeks’ gestation reduces the risk of cerebral palsy in their children. Our study aimed to assess the impact of a local quality improvement programme, primarily using plan-do-study-act cycles, to increase the use of antenatal magnesium sulfate. After implementing our quality improvement programme, an average of 86% of babies delivered at <30 weeks’ gestation were exposed to antenatal magnesium sulfate compared with a historical baseline rate of 63%. Our study strengthens the case for embedding quality improvement programmes in maternal perinatal care to reduce the impact of cerebral palsy on families and society.
2014 ◽
Vol 51
(12)
◽
pp. 1634-1643
◽
2014 ◽
Vol 99
(5)
◽
pp. F395-F401
◽
Keyword(s):
2013 ◽
Vol 65
(3)
◽
pp. 319-332
◽
Keyword(s):
2017 ◽
Vol 22
(3)
◽
pp. 193-198
◽
2014 ◽
Vol 20
(6)
◽
pp. 1137-1143
◽
Keyword(s):